Published online Feb 26, 2025. doi: 10.12998/wjcc.v13.i6.94330
Revised: September 28, 2024
Accepted: November 5, 2024
Published online: February 26, 2025
Processing time: 254 Days and 19.4 Hours
Hydroxyurea, an antimetabolite, is frequently prescribed for various hematological disorders, and its common side effects include gastrointestinal problems, cutaneous or mucosal lesions and pyrexia/fever.
This study reports the case of a 67-year-old woman who developed recurrent abdominal pain after 10 years of continuous hydroxyurea therapy for primary thrombocythemia. Colonoscopy revealed an ileocecal ulcer. After discontinuing hydroxyurea therapy for 6 months, follow-up colonoscopy showed a significant reduction in the ulceration.
We consider cecal ulcers as a rare complication of hydroxyurea therapy which typically resolves upon stopping the drug.
Core Tip: Ileocecal ulcers related to hydroxyurea are a rare adverse reaction and may be associated with drug hypersensitivity vasculitis and Behcet's disease. However, its specific pathogenic mechanism remains unknown. To date, only four cases of ileocecal ulcers have been reported worldwide, including three cases of the condition being complicated by pyrexia/fever, oral ulcers, and xerosis cutis. Pathological findings of ileocecal ulcers in these four cases revealed inflammatory changes that improved after hydroxyurea was discontinued. This report aims to raise awareness of the rare complication of hydroxyurea-induced ileocecal ulcers.